首页/数据集/Rate of achievement of LDL-C and non-HDL-C target at 12<sup>th</sup> week (FA set).

Rate of achievement of LDL-C and non-HDL-C target at 12<sup>th</sup> week (FA set).

NIAID Data Ecosystem2026-03-12 收录

数据链接：

https://figshare.com/articles/dataset/Rate_of_achievement_of_LDL-C_and_non-HDL-C_target_at_12_sup_th_sup_week_FA_set_/13629116 数据链接链接失效反馈

官方服务：

资源简介：

Rate of achievement of LDL-C and non-HDL-C target at 12th week (FA set).

应用场景：

创建时间：

2021-01-22

临床试验终点分析

敏感性分析

an = Day 3 PP population minus six patients (two adults, four children) with ‘poor model fit’ due to the model being inadequate to fit their data. P values that are statistically significant are in it

NIAID Data Ecosystem50

Results for the primary endpoint – effects on the hospitalization rate in the ITT and R-PP-CC population.

临床试验终点分析

住院率疗效评估

Results for the primary endpoint – effects on the hospitalization rate in the ITT and R-PP-CC population.

Figshare2025-05-15 更新30

The patients amount with different numbers of chronic pulmonary disease exacerbations for 24±1 weeks (FAS and PP populations).

慢阻肺急性加重

临床试验终点分析

The patients amount with different numbers of chronic pulmonary disease exacerbations for 24±1 weeks (FAS and PP populations).

Figshare2021-12-23 更新10

Number of improved patients (ΔARATpre-post ≥5) at post-treatment visit in the M-TOT and the C-TOT group, with differences and confidence intervals.

上肢康复疗效评估

临床试验终点分析

Number of improved patients (ΔARATpre-post ≥5) at post-treatment visit in the M-TOT and the C-TOT group, with differences and confidence intervals.

Figshare2017-12-05 更新30

Summary statistics for safety and efficacy endpoints for both the modified safety and per-protocol (PP) populations.

临床试验终点分析

药物安全性评估

Summary statistics for safety and efficacy endpoints for both the modified safety and per-protocol (PP) populations.

NIAID Data Ecosystem10

Rate of achievement of LDL-C and non-HDL-C target at 12<sup>th</sup> week (FA set).

资源简介：

相关数据集